← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2006Last known activity
Apr 1, 2016
Defunct as of Oct 20, 2014
Timeline
2000s
- Jun 1, 2004
CoMentis— Founded
- Apr 13, 2006
Osprey Pharmaceuticals USA, Inc.— Acquired
2010s
- Oct 20, 2014
CoMentis— Defunct
Drugs by trial phase (7 distinct, 11 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 1 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (16)
- NCT02724917Lead sponsorPhase 1/Phase 2Apr 1, 2016
- NCT02331433Lead sponsorPhase 1Dec 1, 2014
- NCT00783068CollaboratorN/AAug 1, 2008
- NCT00607750Lead sponsorPhase 2May 1, 2008
- NCT00607750Study directorPhase 2May 1, 2008
- NCT00536692Lead sponsorPhase 2Sep 1, 2007
- NCT00621010Study directorPhase 1Jun 1, 2007
- NCT00621010Lead sponsorPhase 1Jun 1, 2007
- NCT00414206Lead sponsorPhase 2Mar 1, 2007
- NCT00414206Study directorPhase 2Mar 1, 2007
- NCT00419445Study directorPhase 1/Phase 2Feb 1, 2007
- NCT00419445Lead sponsorPhase 1/Phase 2Feb 1, 2007
- NCT00414622Study directorPhase 2Nov 1, 2006
- NCT00414622Lead sponsorPhase 2Nov 1, 2006
- NCT00316537Study directorPhase 1/Phase 2Oct 1, 2006
Details
- Founded
- South San Francisco, CA, US Jun 1, 2004
- Last known activity
- Apr 1, 2016